Suppression of murine collagen-induced arthritis by nasal administration of collagen

Immunology

Volumn 90, Issue 2, 1997, Pages 161-164

  Myers, L K ^a   Seyer, J M ^a,b   Stuart, J M ^a,b   Kang, A H ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNITY; COMPLEMENT FIXATION; CONTROLLED STUDY; DOWN REGULATION; ETIOLOGY; H2 SYSTEM; HELPER CELL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031027306     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00191.x     Document Type: Short Survey

References (17)

1. TRENTHAM D.E., TOWNES A.S. & KANG A.H. (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146, 857.
2. CREMER M.A., HERNANDEZ A.D., STUART J.M., TOWNES A.S. & KANG A.H. (1983) Collagen-induced arthritis in rats: Antigen specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol 131, 2995.
3. NAGLER-ANDERSON C.N., BOBER L.A., ROBINSON M.E., SISKIND G.W. & THORBECKE G.J. (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83, 7443.
4. THOMPSON H.S. & STAINES N.A. (1986) Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64, 581.
5. CIBOTTI R., KANELLOPOULOS J.M., CABANIOLS J.-P. et al. (1992) Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci USA 89, 416.
6. GAMMON G., SERCARZ E. & BENICHOU G. (1991) The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol Today 12, 193.
7. KOURILSKY P., JAULIN C. & LEVY V. (1991) The structure and function of MHC molecules. Possible implications for the control of tumor growth by MHC-restricted T cells. Semin Cancer Biol 2, 275.
8. MYERS L.K., STUART J.M., SEYER J.M. & KANG A.H. (1989) Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med 170 (1999)
9. MYERS L.K., TERATO K., SEYER J.M., STUART J.M. & KANG A.H. (1992) Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J Immunol 149, 1439.
10. q mice. J Immunol 152, 3088.
11. MYERS L.K., STUART J.M. & KANG A.H. (1989) A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J Immunol 143, 3976.
12. MA C., ZHANG G., XIAO B. et al. (1996) Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-γ expressing Th1-like cells and up-regulation of TGF-ß mRNA in mononuclear cells. Ann NY Acad Sci 778, 273.
13. HOYNE G., O'HEHIR R., WRAITH D., THOMAS W. & LAMB J. (1993) Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 178, 1783.
14. DICK A., CHENG Y., LIVERSIDGE J. & FORRESTER J. (1994) Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology 82, 625.
15. STAINES N., HARPER N., WARD F., MALMSTROM V., HOLMDAHL R. & BANSAL S. (1996) Mucosal tolerance and suppression of collagen-induced arthritis (CIA) by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 103, 368.
16. WRAITH D. (1996) Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin Exp Immunol 103, 349.
17. WOOLEY P.H., LUTHRA H.S., STUART J.M. & DAVID C.S. (1981) Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154, 688.